Immune Checkpoint Blockade in Hepatocellular Carcinoma: Current Progress and Future Directions

被引:198
作者
Hato, Tai [1 ]
Goyal, Lipika [2 ]
Greten, Tim F. [3 ]
Duda, Dan G. [1 ]
Zhu, Andrew X. [2 ]
机构
[1] Massachusetts Gen Hosp, Dept Radiat Oncol, Edwin L Steele Lab, Boston, MA 02114 USA
[2] Massachusetts Gen Hosp, Ctr Canc, Dept Med, Boston, MA 02114 USA
[3] NCI, Gastrointestinal Malignancy Sect, Thorac & Gastrointestinal Oncol Branch, Bethesda, MD 20892 USA
基金
美国国家卫生研究院;
关键词
REGULATORY T-CELLS; PERCUTANEOUS ETHANOL INJECTION; SUPPRESSOR-CELLS; POSTOPERATIVE RECURRENCE; CTLA-4; BLOCKADE; LIVER; RESPONSES; PD-1; MOLECULES; HEPATITIS;
D O I
10.1002/hep.27246
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Immune checkpoint blockade has recently emerged as a promising therapeutic approach for various malignancies including hepatocellular carcinoma (HCC). Preclinical and clinical studies have shown the potential benefit of modulating the immunogenicity of HCC. In addition, recent advances in tumor immunology have broadened our understanding of the complex mechanism of immune evasion. In this review we summarize the current knowledge on HCC immunology and discuss the potential of immune checkpoint blockade as a novel HCC therapy from the basic, translational, and clinical perspectives.
引用
收藏
页码:1776 / 1782
页数:7
相关论文
共 63 条
[1]   Analysis of CD4+ T-cell responses to a novel α-fetoprotein-derived epitope in hepatocellular carcinoma patients [J].
Alisa, A ;
Ives, A ;
Pathan, AA ;
Navarrete, CV ;
Williams, R ;
Bertoletti, A ;
Behboudi, S .
CLINICAL CANCER RESEARCH, 2005, 11 (18) :6686-6694
[2]   Increase in CD14+HLA-DR-/low myeloid-derived suppressor cells in hepatocellular carcinoma patients and its impact on prognosis [J].
Arihara, Fumitaka ;
Mizukoshi, Eishiro ;
Kitahara, Masaaki ;
Takata, Yoshiko ;
Arai, Kuniaki ;
Yamashita, Tatsuya ;
Nakamoto, Yasunari ;
Kaneko, Shuichi .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2013, 62 (08) :1421-1430
[3]   Restoring function in exhausted CD8 T cells during chronic viral infection [J].
Barber, DL ;
Wherry, EJ ;
Masopust, D ;
Zhu, BG ;
Allison, JP ;
Sharpe, AH ;
Freeman, GJ ;
Ahmed, R .
NATURE, 2006, 439 (7077) :682-687
[4]   Phase I safety and pharmacokinetic study of CT-011, a humanized antibody interacting with PD-1, in patients with advanced hematologic malignancies [J].
Berger, Raanan ;
Rotem-Yehudar, Rinat ;
Slama, Gideon ;
Landes, Shimon ;
Kneller, Abraham ;
Leiba, Merav ;
Koren-Michowitz, Maya ;
Shimoni, Avichai ;
Nagler, Arnon .
CLINICAL CANCER RESEARCH, 2008, 14 (10) :3044-3051
[5]   Tremelimumab for patients with chemotherapy-resistant advanced malignant mesothelioma: an open-label, single-arm, phase 2 trial [J].
Calabro, Luana ;
Morra, Aldo ;
Fonsatti, Ester ;
Cutaia, Ornella ;
Amato, Giovanni ;
Giannarelli, Diana ;
Di Giacomo, Anna Maria ;
Danielli, Riccardo ;
Altomonte, Maresa ;
Mutti, Luciano ;
Maio, Michele .
LANCET ONCOLOGY, 2013, 14 (11) :1104-1111
[6]   Selective Recruitment of Regulatory T Cell through CCR6-CCL20 in Hepatocellular Carcinoma Fosters Tumor Progression and Predicts Poor Prognosis [J].
Chen, Kang-Jie ;
Lin, Sheng-Zhang ;
Zhou, Lin ;
Xie, Hai-Yang ;
Zhou, Wu-Hua ;
Taki-Eldin, Ahmed ;
Zheng, Shu-Sen .
PLOS ONE, 2011, 6 (09)
[7]   Molecular mechanisms of T cell co-stimulation and co-inhibition [J].
Chen, Lieping ;
Flies, Dallas B. .
NATURE REVIEWS IMMUNOLOGY, 2013, 13 (04) :227-242
[8]   Engagement of cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) induces transforming growth factor β (TGF-β) production by murine CD4+ T cells [J].
Chen, WJ ;
Jin, WW ;
Wahl, SM .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 188 (10) :1849-1857
[9]   Differential Effects of Sorafenib on Liver Versus Tumor Fibrosis Mediated by Stromal-Derived Factor 1 Alpha/C-X-C Receptor Type 4 Axis and Myeloid Differentiation Antigen-Positive Myeloid Cell Infiltration in Mice [J].
Chen, Yunching ;
Huang, Yuhui ;
Reiberger, Thomas ;
Duyverman, Annique M. ;
Huang, Peigen ;
Samuel, Rekha ;
Hiddingh, Lotte ;
Roberge, Sylvie ;
Koppel, Christina ;
Lauwers, Gregory Y. ;
Zhu, Andrew X. ;
Jain, Rakesh K. ;
Duda, Dan G. .
HEPATOLOGY, 2014, 59 (04) :1435-1447
[10]   Intratumoural GM-CSF microspheres and CTLA-4 blockade enhance the antitumour immunity induced by thermal ablation in a subcutaneous murine hepatoma model [J].
Chen, Zubing ;
Shen, Shiqiang ;
Peng, Baogang ;
Tao, Jianpin .
INTERNATIONAL JOURNAL OF HYPERTHERMIA, 2009, 25 (05) :374-382